Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

TabacaleraYsidron

2011 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Mount TAM Biotechnologies Inc is a biopharmaceutical company operating in the US. Its core business is to optimize, develop a portfolio of products focused on improving the health and wellbeing of individuals afflicted with serious diseases, with a key product targeting systemic lupus erythematosus (SLE) and a strategy to bring to market novel therapeutics across a range of serious disease areas. The company mainly focuses on the development of a product candidate in the field of SLE, an autoimmune disorder where treatments are inadequate to control disease and a condition where serious unmet need remains. It product candidates is TAM-01 and TAM-03 which are novel rapalogs in action of binding and inhibition of the mammalian Target of Rapamycin.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Consumer Non-Durables
Primary Office
  • 100 Europa Drive
  • Suite 455
  • Chapel Hill, NC 27517
  • United States

TabacaleraYsidron Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore TabacaleraYsidron‘s full profile, request access.

Request full access to PitchBook